Viewing Study NCT00989404

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2026-05-05 @ 9:55 AM
Study NCT ID: NCT00989404
Status: COMPLETED
Last Update Posted: 2017-06-14
First Post: 2009-09-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza A Virus, H1N1 Subtype View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pk View
None healthy subjects View
None influenza virus View
None Safety View
None pandemic View